The sarcoidosis genetic analysis (SAGA) study previously identified eight chromosomal regions with suggestive evidence for linkage to sarcoidosis susceptibility in African-American sib pairs. Since the clinical course of sarcoidosis is variable and likely under genetic control, we used the affected relative pair portion of the SAGA sample (n ¼ 344 pairs) to perform multipoint linkage analyses with covariates based on pulmonary and organ involvement phenotypes. Chest radiographic resolution was the pulmonary phenotype with the highest LOD (logarithm of the backward odds, or likelihood ratio) score of 5.11 at D1S3720 on chromosome 1p36 (P ¼ 4 Â 10
Introduction
Genetic linkages to sarcoidosis have been reported in a German white population 1 with fine mapping of the strongest linkage signal on chromosome 6p revealing a human leukocyte antigen (HLA) class II co-stimulatory gene, BTNL2 (MIM 606000). 2 More recently, we reported from the sarcoidosis genetic analysis (SAGA) study, the first genome scan in African Americans, several regions of suggestive linkage to sarcoidosis susceptibility with the most prominent peak at D5S2500 on chromosome 5q11. 3 The disparity in results between the two genome scans and the phenotypic variability of sarcoidosis suggest that linkage analysis of specific sarcoidosis phenotypes may discover disease genes that analyses of sarcoidosis susceptibility alone have failed to detect.
Rather than a distinct clinical entity, sarcoidosis may be one clinical manifestation of a constellation of immune-related inflammatory granulomatous disorders that lie on a continuous disease spectrum. 4 Inflammatory diseases share genetic risk factors, 5 which suggests that searching for genes linked to specific clinical manifestations rather than a clinically defined inflammatory disorder might prove more informative. This approach has been successfully used in fine mapping systemic lupus erythematosus, 6 where restricting the analysis to particular phenotypes led to greater genetic homogeneity for this complex disease. Another example is in asthma, where genetic linkage analyses of specific asthma phenotypes, for example, bronchial hyperreactivity, have also proved fruitful. 7 In an effort to simplify phenotyping, sarcoidosis has commonly been classified as 'chronic' or 'acute' disease. While this phenotyping scheme is probably an oversimplification, genetic factors specific to these phenotypes have been identified. For instance, the class II HLA-DRB1*0301/DQB1*0201 haplotype has been repeatedly found associated with Lofgren's syndrome, [8] [9] [10] [11] an acute form of sarcoidosis characterized by erythema nodosum, Scadding stage I chest X-ray, arthritis and a good prognosis. 12 More generally, this haplotype is also associated with a good disease prognosis. 11, 13, 14 In the SAGA sib pair study, we reported that for the 26% of sarcoidosis cases with ocular and 16% with liver involvement, the other affected sib in the pair was three times more likely to also have the same organ affected. 15 Genes that underlie this type of phenotypic concordance may be better elucidated by targeted analyses of sarcoidosis phenotypes.
In the present study, we utilized the 344 AfricanAmerican affected relative pairs (ARPs) of the SAGA study population in an attempt to genetically dissect the sarcoidosis phenotype according to the extent of pulmonary and extrathoracic organ involvement. The purpose was to determine through genetic linkage analyses how similar, if at all, the genetic linkage signals for sarcoidosis phenotypes in African Americans were to those signals we previously identified for disease susceptibility.
Results

Familial correlations
Of the two pulmonary phenotypes, chest radiographic resolution had the strongest sib pair correlation among full sib pairs (r ¼ 0. 302; P ¼ 0.0004) and all relative pairs (r ¼ 0.227; P ¼ 0.002). Among the extrathoracic organ involvement phenotypes, in both full sib pairs as well as all relative pairs, bone marrow involvement (r ¼ 0.523; Po0.0001 in full sib pairs; r ¼ 0.401; Po0.0001 in all relative pairs) and ocular involvement (r ¼ 0.293; Po0.0001 in full sib pairs; r ¼ 0.230; Po0.0001 in all relative pairs) had the strongest correlations (Table 1) .
Genetic linkage of single pulmonary and organ-related phenotypes Using these phenotypic outcomes as covariates, we ran separate linkage models with LODPAL that estimated a parameter for the 'average' linkage in the sample, as well as a parameter for the change in linkage as a function of the phenotypic covariate. Table 2 reports the LOD scores of 2 or greater for the single covariate models of pulmonary and organ-related phenotypes, together with the P values corresponding to the change in linkage as a function of the phenotype covariate. A LOD score of 5.11 (P ¼ 4 Â 10
À5
) at the chromosome 1p36 marker D1S3720 was observed for the model with the radiographic resolution covariate. LOD scores for all other pulmonary-related phenotypes were between 2.10 and 3.13. Of the models including a covariate for the 10 different extrathoracic organ involvement phenotypes, the model with a covariate for bone marrow involvement attained a LOD score of 2 or greater at four separate regions: D6S1056 (LOD ¼ 3.96; P ¼ 0.0003), D10S1225 (LOD ¼ 3.63; P ¼ 0.0004), D12S1052 (LOD ¼ 3.97; P ¼ 0.0003) and D13S787 (LOD ¼ 4.68; P ¼ 0.0001). Eight of the other organ systems had one or more regions with LOD scores greater than 2, including skin (D5S816, D10S1248 and D11S1392) and renal (D2S2986, D18S1364 and D22S532), with three regions each. Among the increased LOD scores for organ system involvement, the most statistically significant was the LOD score of 5.70 (P ¼ 2 Â 10
) at D3S3630 for spleen involvement.
Bivariable pulmonary-related phenotype models While the two pulmonary-related phenotypes measured different outcomes that may each be under the control of a unique set of genes, the two phenotypes were correlated with each other and may also share common genetic risk factors. Therefore, we tested bivariable LODPAL models that included two covariates, respectively, for radiographic resolution and forced vital capacity (FVC) at follow-up. Significance levels were larger for these two-covariate models owing to the added degree of freedom, but in some instances, the LOD scores were greatly increased. On chromosomes 2 (Figure 1a . The model that included both covariates had a peak LOD score of 3.87 (P ¼ 0.002), 7 cM from D6S1056 (107 cM). On chromosome 14, peak LOD scores for radiographic resolution and FVC at follow-up were 1.97 at 16 cM and 2.10 at 44 cM, but in the bivariable model the peak LOD score was 4.26 (P ¼ 0.001) at 24 cM ( Figure 1d ). Similarly, on chromosome 22, peak LOD scores for radiographic resolution and FVC at follow-up were separately 2.35 at 41 cM and 2.12 at 41 cM, but in the bivariable model the peak LOD score was 4.60 (P ¼ 0.0006) at 34 cM ( Figure 1f ). The chromosomes with increased bivariable LOD scores can be contrasted with the peak LOD score of 5.11 at chromosome 1p36 observed for radiographic resolution in the single covariate model. The two covariate model that included radiographic resolution and FVC at follow-up (LOD ¼ 4.48) did not result in a markedly increased LOD score in comparison with the single covariate model for radiographic resolution, which suggests that the additional pulmonary phenotype covariate of FVC at follow-up did not provide any additional information in terms of explaining the genetic variance at the chromosome 1 locus.
Genetic linkage of clustered organ involvement phenotypes
The 10 organ systems fell into four clusters that explained 50% of the total organ system involvement variance. Table 3 shows the intra-and inter-cluster correlation for each of the 10 organ systems. In general, the variables within each of the four clusters were highly correlated and had low correlation with variables outside their respective clusters. Based on these clusters, four additional covariates were formed that represented having at least one of the organ systems affected in each respective cluster. In LODPAL analyses with these cluster variables as covariates (Table 4) , the highest LOD score was for the cardiac/renal cluster with a LOD score of 6.65 at 108 cM (4 cM from the ATA83B02 marker) of chromosome 18q22 (P ¼ 2 Â 10
À5
). The cluster variable with the next highest LOD score was the neuro/lymph group with LOD scores of 4.61 (P ¼ 0.0001), 5.16
) and 4.07 (P ¼ 0.0002) at D1S534, D7S3056 and D15S1507, respectively. The highest LOD score for the liver/spleen/marrow group was 3.72 (P ¼ 0.0004) at D10S1426. For the ocular/skin/joint group, the highest LOD score was 2.93 (P ¼ 0.001) at D10S1248.
Discussion
While several previously published reports of phenotypic similarities among relatives with sarcoidosis exist, the extent to which phenotypic concordance in sarcoidosis affected relatives is under genetic control is unknown. Sharma et al. 16 reported a sibship of size 4 in which all had sarcoidosis and three presented with parotid enlargement and liver involvement. In 22 French families, of which two had three members diagnosed with sarcoidosis and the remaining families had two affected members, dates of disease presentation tended to be very close to each other, especially in monozygotic twins, and similarities in the clinical and radiological features of sibs also existed. 17 In one report of three cases of sarcoidosis in a black family, two of the affected sisters had a similar clinical presentation with thoracic, skin, peripheral lymph node and muscle involvement, and poor response to corticosteroids. 18 In the SAGA study population, 19 we found that if a sarcoidosis case had an affected sib with either ocular or liver involvement, he or she was three times more likely to have the same organ affected. 15 In the present study, we used an affected relative pair approach to search for genes influencing sarcoidosis phenotypes and found several novel regions with suggestive linkage to sarcoidosis pulmonary and organrelated phenotypes. The strongest linkage signal for pulmonary phenotypes was a LOD score of 5.11 (P ¼ 4 Â 10
À5
) for radiographic resolution, at chromosome 1p36. An asthma susceptibility locus has also been mapped to this same location in the Collaborative Study on the Genetics of Asthma. 25 Of the 10 organ systems analyzed, bone marrow involvement had the strongest relative pair correlation and the most regions with significantly elevated LOD scores (n ¼ 4). The genetics of bone marrow involvement in sarcoidosis is relatively unknown. We know of only one published study that has reported any genetic association with bone marrow involvement in sarcoidosis. Rossman et al. 26 reported in the ACCESS African-American case-control sample that cases who carried the HLA-DRB3 allele were 6.7 times more likely to have bone marrow involvement. We failed to find any suggestion of linkage of the phenotypes Genetics of sarcoidosis phenotypes BA Rybicki et al studied to the human leukocyte antigen (HLA) region of chromosome 6p21 despite spacing markers at closer intervals (B2-3 cM) in this region. Since extrathoracic organ involvement in sarcoidosis often includes a constellation of affected organs, 20 and because it is unlikely that these constellations are random in their occurrence, we performed a cluster analysis on the 10 organ systems. The strongest linkage signal in our sarcoidosis phenotype genome scan was the clustered phenotype of cardiac/renal involvement at the ATA82B02 marker on chromosome 18q22 (LOD ¼ 6.65;
). A recent genome scan of diabetic nephropathy in African Americans had a linkage signal in this same region with a maximum LOD score of 3.72 in ordered subset analysis of families with cases of diabetes diagnosed at an earlier age. 21 Another genome scan of diabetic nephropathy found strong evidence for a gene in Turkish type II diabetes mellitus patients that also mapped to chromosome 18q22. 22 Possible sarcoidosis candidate genes on chromosome 18q22 include the suppressor of cytokine signaling 6 (SOCS6) and CD226 (MIM 605397) genes. SOCS6 resides approximately 0.8 megabases from the marker on 18q, ATA82B02 that had the highest LOD score in our study. SOCS6 is part of the suppressors of cytokine signaling family consisting of eight proteins (CIS and SOCS-1-7) that were first characterized as negative feedback regulators for cytokine receptor signaling. Members of this family of genes are likely involved in inflammatory diseases. 23 The exact function of SOCS6 is unknown, but one study suggests it may be a negative regulator of receptor tyrosine kinases. 24 CD226, which resides approximately 1.2 megabases from ATA82B02 on 18q, is a costimulatory molecule that plays an important role in activation and effector functions of Th1 cells and is specifically expressed on the surface of differentiated Th1 cells. While the clustered phenotypes generally provided more linkage information than analyses of single organ systems, both the linkage peak at D10S1248, and that observed at D5S816 for the ocular/skin/joint clustered covariate were also observed in the linkage analyses that included a covariate for skin alone, suggesting that skin involvement was driving the linkage signals in the analyses of the ocular/skin/joint cluster.
In comparing the most significant results of our previous genome scan of sarcoidosis susceptibility 3 with the most prominent phenotype linkage peaks on the comparable chromosomes, there was limited overlap in linkage signals (Table 5 ). For four of the six chromosomes with suggestive linkage peaks for disease susceptibility, the most prominent phenotype linkage peak was far enough away from the susceptibility peak so as to Genetics of sarcoidosis phenotypes BA Rybicki et al represent a separate linkage signal (the closest pair of peaks were over 40 megabases apart). Only six megabases separated the susceptibility and phenotype (cardiac/renal) linkage peaks on chromosome 9 and the chromosome 20 linkage peaks for susceptibility and phenotype (neuro/lymph) shared the same marker. However, neither of these phenotype peaks represented the most significant for that particular phenotype. In the genome scan for susceptibility that used all 516 sib pairs, a modest nonsignificant peak (P ¼ 0.2) was found at the chromosome 18q22 marker ATA82B02 that had the smallest significance level (P ¼ 2 Â 10
) in the phenotype genome scan (clustered cardiac/renal phenotype). When only affected sibs were used in the susceptibility scan, the P value at this marker decreased to 0.04. Overall, it appears from these results that major genetic loci influencing sarcoidosis susceptibility and specific clinic phenotypes are largely separate.
The SAGA sib pair study sample was over five times larger than the only other genome scan conducted for sarcoidosis, but organ involvement data was missing on approximately 10% of the 505 affected sibs. A similar percentage of pulmonary function and/or radiographic data were also missing. While, ostensibly, this percent of missing data should not bias our results, it nevertheless reduces our overall statistical power to detect linkage to sarcoidosis phenotypes. Unobserved disease organ involvement outcomes due to incomplete clinical surveillance also compromised the study's statistical power, but only a prospective study within a controlled clinical environment could fully address this problem, and such a study would be logistically difficult to conduct. Genetic heterogeneity due to variable genetic admixture proportions within our study population may have also limited our study power, as was the case with disease susceptibility, which we have previously demonstrated. 30 In studying specific disease phenotypes, we might hope genetic heterogeneity becomes less of an issue, since the aim of phenotype analysis is to target patient subsets with more genetic homogeneity.
In summary, we have demonstrated that the inclusion of various pulmonary and organ-related phenotypes as covariates in a linkage analysis of susceptibility to sarcoidosis uncovers evidence for novel linkages in African-American ARPs, which implies that these specific sarcoidosis phenotypes may be under a genetic influence separate from susceptibility loci. In terms of fine mapping genes underlying sarcoidosis phenotypes, our results suggest modeling multiple related phenotypes together and/or phenotype clustering may optimize the utility of sarcoidosis clinical outcome data that are often incomplete. Efforts are underway to apply novel statistical methodologies to tease out genetic effects underlying sarcoidosis phenotypes amenable to fine mapping and gene localization.
Materials and methods
Recruitment and description of study sample The study protocol was reviewed and approved by the institutional review boards for human subject research at each participating institution. Recruitment began within the pulmonary clinics of SAGA study investigators, but also extended out to additional clinics. Families were ascertained through two or more medically documented sarcoidosis cases who self-reported their ethnic background as black or African American. In total, 338 affected sib pairs (ASP) from 229 nuclear families were available for analysis. Two sets of two nuclear families were connected, which allowed the addition of six avuncular affected pairs to the dataset, resulting in a total of 344 ARPs for analysis. The ASP sample comprised 252 full sib pairs (74.6%) and 86 half sib pairs (25.4%) there being 229 index cases and 276 affected relatives (n ¼ 505). The mean7standard deviation age at diagnosis of index cases and affected relatives was 35.579.1 and 34.279.5, respectively. Index cases were more likely to be female compared with affected relatives (82 vs 70%; P ¼ 0.002). Overall, the average length of follow-up was greater than 10 years for all affected family members (Table 6 ), but approximately 5% had less than 2 years of follow-up, which precluded complete phenotyping in some instances. More detailed descriptions of the study sample, recruitment methodology and genotyping can be found in previous publications. 3, 19 Genotyping and model-free linkage analysis A fluorescence-based genotyping method was used to type the Weber 10 microsatellite marker set, which consists of 380 markers across 22 autosomes spaced an average of 9.18 cM apart. To investigate the genetic linkage of sarcoidosis phenotypes, we reanalyzed these genotype data from the SAGA study 3 using an affected relative pair multipoint genetic linkage analysis approach implemented in the program LODPAL of the S.A.G.E. software suite. 31 This statistical method was first introduced by Olson 32 and was later modified by Goddard et al. 33 to allow inclusion of covariates. It is Phenotypes Table 6 displays the follow-up time and missing phenotype data for the affected index case and his or her affected relative. SAGA was an observational study, and therefore, all phenotype data representing the patient's experience from diagnosis to time of enrollment was abstracted from regular medical care visits. Pulmonary phenotypes included FVC at follow-up (where follow-up was a minimum of 2 years) and radiographic resolution. FVC is a pulmonary function measure of lung size and is based on the volume change of the lung between a full inspiration to total lung capacity and a maximal expiration to residual volume. Physiologically, in interstitial lung diseases such as sarcoidosis, FVC can be used as a non-specific quantitative measure of lung damage that causes a reduction in inspiration capacity. Chest radiographs at diagnosis and during disease follow-up were scored using the sarcoidosis Scadding staging scale 35 that ranges from I (bilateral adenopathy) to IV (pulmonary fibrosis). Stage 0 represents a normal chest X-ray. Radiographic resolution was defined as having a Scadding stage I or higher chest X-ray (that is, radiographic evidence of disease) at diagnosis that later reverted to normal with a minimum of 2 years of followup. Organ involvement was based on medical record review per the criteria outlined in Judson et al., 36 and included assessment of the following 10 organ systems: skin, bone marrow, liver, ocular, cardiac, renal, spleen, joint, neuro and extrathoracic lymph glands.
Cluster analysis
We grouped organ systems using the VARCLUS procedure in SAS 37 that utilizes an oblique principal component analysis. VARCLUS attempts to split variables into clusters (or factors) in such a way as to maximize the amount of variation in the data explained by the top few principal components. Because the variance explained by the components is maximized, variables loaded onto a cluster will tend to be correlated, whereas variables in distinct clusters will tend to be uncorrelated. The variable groupings that comprised each of the identified principal components were examined as single covariates in LODPAL linkage analyses.
